A women’s health company on a mission to eliminate cervical cancer by making screening accessible, comfortable, and accurate
San Francisco, California, U.S.Healthtech
| Round | Amount | Announced | Lead | Verified | Status | Sources |
|---|---|---|---|---|---|---|
| Series A Series A | $22M | 2026-09-22 | .406 Ventures | 5 | [ PUBLISHED ] | 5 |
[ BUILT WITH ]·[ SEARCH ]found by corroboration·[ SCRAPE ]5 pages read: pulse2.com, techstartups.com, getteal.com·[ JSON ]round extracted with a schema, grounded to one sentence·[ VERIFY ]correctedread back against its page by Firecrawl·[ BRANDING ]homepage not matched·[ AGENT ]dossier built by the Firecrawl agent | ||||||
Teal Health makes an FDA-authorized at-home cervical-cancer screening kit and telehealth service for women and people with a cervix.
| Round | Amount | Announced | Lead |
|---|---|---|---|
| pre-seed funding | $1M | 2021 | not stated |
| seed round | $8.8 million | 2023-01-31 | not stated |
| seed funding | $10 million | 2025-01-16 | Emerson Collective, Forerunner |
Teal is addressing a screening-access problem: its pages say roughly one in four women is not routinely screened, while traditional screening can be difficult to access and uncomfortable. Its FDA-authorized home device and telehealth workflow have screened thousands of women, and the company says its $22 million Series A will expand payer, health-system, employer and provider partnerships ahead of broad insurance coverage in 2027.
No homepage passed the identity check, so nothing was written. Refresh profile tries again with what the record now knows.